GlassScriptPhysician profile
Mohammad M Rahman
NPI 1902803075
$16,301.69
in general payments reported to CMS, 2019-2025
9 companies · $28.91 in 2025
The $28.91 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $15.41 · 2021: $26.12 · 2023: $170 · 2024: $16K · 2025: $28.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,900.00 |
| Food and Beverage | $225.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $15,900.00 | 2024 | Smartablatetm System Rf Generator |
| Boston Scientific Corporation | $145.27 | 2023 | Watchman Access System |
| Novartis Pharmaceuticals Corporation | $122.03 | 2019 | |
| Daiichi Sankyo INC. | $28.91 | 2025 | Enhertu |
| Mindray Ds USA, INC. | $26.96 | 2024 | A7 Anesthesia System |
| Genzyme Corporation | $26.12 | 2021 | |
| Acadia Pharmaceuticals INC | $24.31 | 2023 | Nuplazid |
| Foundation Medicine, INC. | $15.41 | 2020 | |
| Biotronik INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.